ArticleCureus2026
Pediatric Allergy to Poultry Meat: A Case of Egg-Bird Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poultry meat allergy is a rare condition that can present as a primary allergy or a secondary syndrome, such as the egg-bird syndrome. This syndrome involves primary sensitization to egg yolk (alpha-livetin (Gal d 5)) leading to cross-reactivity with poultry meat. We describe the case of a 12-year-old male patient who presented with a history of primary egg allergy and allergy to dog epithelium. He subsequently developed an allergy to poultry meat. Immunoallergological evaluation showed sensitization to egg yolk, chicken meat, and alpha-livetin (Gal d 5). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) immunoblotting confirmed immunoglobulin E (IgE) reactivity to alpha-livetin and avian muscle serum albumin, with no cross-reactivity to dog epithelium. This confirmed the diagnosis of egg-bird syndrome. Due to severe asthma and multiple food allergies impacting his quality of life, the patient was treated with omalizumab. This case highlights the clinical complexity of the egg-bird syndrome and the utility of molecular diagnostics in differentiating cross-reactivities. Omalizumab proved effective in managing the patient's polysensitization and asthma, improving quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.